A Study of AK120 (IL-4Rα) in Healthy Subjects and Subjects With Moderate- to- Severe Atopic Dermatitis

Clinical trial NCT04256174 · COMPLETED

Trial details

NCT number: NCT04256174
Sponsor: Akesobio Australia Pty Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2020-06-15
Primary completion: 2021-10-29
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.